1. Home
  2. Material Detail: Liability Issues Associated With the Administration of Allergen Immunotherapy

Material Detail

Liability Issues Associated With the Administration of Allergen Immunotherapy

Liability Issues Associated With the Administration of Allergen Immunotherapy

This article discusses the liability behind the delay of administering epinephrine or lack to administer epinephrine to patients with severe or anaphylactic shock. Further more, this articles discusses the guidelines implemented by the American Academy of Allergy, Asthma, and Immunology (AAAAI) and the American College of Allergy, Asthma and Immunology (ACAAI)....

Show More
Keywords:
Immunology, Anaphylaxis, Allergy
Disciplines:
Go to Material 
Bookmark / Add to Course ePortfolio
Create a Learning Exercise
Add Accessibility Information
Rate
Add a Comment

Quality

  • User Rating
  • Comments
  • Learning Exercises
  • Bookmark Collections
  • Course ePortfolios
  • Accessibility Info

More about this material

Material Type:
Collection
Date Added to MERLOT:
June 20, 2017
Date Modified in MERLOT:
March 16, 2021
Author:
Unknown (Know the author?)
Submitter:
Silvia Carrillo
Primary Audience:
College General Ed, College Lower Division, College Upper Division, Graduate School, Professional
Technical Format:
Document, PDF, Website
Mobile Compatibility:
Not specified at this time
Language:
English
Cost Involved:
Unknown
Source Code Available:
Unknown
Creative Commons:
No

Browse...

Disciplines with similar materials as Liability Issues Associated With the Administration of Allergen Immunotherapy
People who viewed this also viewed
Other materials like Liability Issues Associated With the Administration of Allergen Immunotherapy

Comments

Log in to participate in the discussions or sign up if you are not already a MERLOT member.